Sanofi Closes on UK Biotechnology Company Vicebio

MT Newswires · 3d ago
06:27 AM EST, 12/04/2025 (MT Newswires) -- Sanofi (SAN.PA) completed the acquisition of London-based biotechnology company Vicebio, according to a Thursday release. The deal gives Sanofi access to an early-stage combination vaccine candidate for respiratory syncytial virus and human metapneumovirus, as well as to Vicebio's molecular clamp technology.